Next Article in Journal
RUVBL1 in Clear-Cell Renal Cell Carcinoma: Unraveling Prognostic Significance and Correlation with HIF1A
Next Article in Special Issue
Machine Learning Applied to Pre-Operative Computed-Tomography-Based Radiomic Features Can Accurately Differentiate Uterine Leiomyoma from Leiomyosarcoma: A Pilot Study
Previous Article in Journal
Locoregional Therapies for Hepatobiliary Tumors: Contemporary Strategies and Novel Applications
Previous Article in Special Issue
Sarcopenic Obesity in Cervical Carcinoma: A Strong and Independent Prognostic Factor beyond the Conventional Predictors (ESTHER Study—AFRAID Project)
 
 

Order Article Reprints

Journal: Cancers, 2024
Volume: 16
Number: 1272

Article: Modulation of sHLA-G, PD-1, and PD-L1 Expression in Cervical Lesions Following Imiquimod Treatment and Its Association with Treatment Success
Authors: by Andrej Cokan, Neila Caroline Henrique da Silva, Rajko Kavalar, Igor But, Maja Pakiž, Sheilla Andrade de Oliveira, Fabiana Oliveira dos Santos Gomes, Rodrigo Soares da Silva, Christina Alves Peixoto and Norma Lucena-Silva
Link: https://www.mdpi.com/2072-6694/16/7/1272

MDPI provides article reprints in high quality with convenient shipping to destinations worldwide. The articles are printed in on premium paper with high-resolution figures. Our covers are customized to your article and designed to be complimentary to the journal. These reprints are ideal additions to your portfolio. Copy details: 135g/m2 paper, 2x stitched, full colour and glossy finish, orderable in quantities from 10 to 1000.

If you have any questions, or special requests, please write to our support team; we are happy to provide you with the information you need.

Reprint Options

If you need more than 400 copies, please contact us by e-mail (articlereprints@mdpi.com) and we will prepare an individual offer for you.

Order Cost and Details

Contact Person

Invoice Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop